Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thure Filskov Overvad

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Thrombolysis|January 28, 2024
Trends of Pulmonary Embolism-Related Sudden Cardiac Death in the United States, 1999-2019Marco Zuin, Thure Filskov Overvad, Ida Ehlers Albertsen, et al.
European Journal of Epidemiology|January 12, 2026
Quality of cancer-related data from the Danish National patient registry (1994-2025) and the Danish cancer registry (2004-2025): a systematic reviewAmalie Helme Simoni, Kathrine Hald, Thure Filskov Overvad, et al.
Current Opinion in Cardiology|July 15, 2015
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemicsIda Ehlers Albertsen, Thure Filskov Overvad, Gregory Y H Lip, et al.
Danish Medical Journal|June 7, 2024
Validity of obstructive sleep apnoea diagnosesEmilia Colding Ofverlind, Jesper Bille, Thure Filskov Overvad, et al.
Circulation|February 21, 2018
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA<sub>2</sub>DS<sub>2</sub>-VA Score Rather Than CHA<sub>2</sub>DS<sub>2</sub>-VASc?Peter Brønnum Nielsen, Flemming Skjøth, Thure Filskov Overvad, et al.
Scientific Reports|June 7, 2016
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort studyPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, et al.
Nature Communications|August 7, 2024
Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohortPeter Brønnum Nielsen, Rasmus Froberg Brøndum, Anne Krogh Nøhr, et al.
Drugs|August 11, 2012
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysisIda Ehlers Albertsen, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, et al.
ESC Heart Failure|February 1, 2018
Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort studyLine Melgaard, Thure Filskov Overvad, Flemming Skjøth, et al.
The American Journal of Medicine|July 8, 2020
Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?Thure Filskov Overvad, Flemming Skjøth, Ida Ehlers Albertsen, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Thrombolysis|January 28, 2024
Trends of Pulmonary Embolism-Related Sudden Cardiac Death in the United States, 1999-2019Marco Zuin, Thure Filskov Overvad, Ida Ehlers Albertsen, et al.
European Journal of Epidemiology|January 12, 2026
Quality of cancer-related data from the Danish National patient registry (1994-2025) and the Danish cancer registry (2004-2025): a systematic reviewAmalie Helme Simoni, Kathrine Hald, Thure Filskov Overvad, et al.
Current Opinion in Cardiology|July 15, 2015
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemicsIda Ehlers Albertsen, Thure Filskov Overvad, Gregory Y H Lip, et al.
Danish Medical Journal|June 7, 2024
Validity of obstructive sleep apnoea diagnosesEmilia Colding Ofverlind, Jesper Bille, Thure Filskov Overvad, et al.
Circulation|February 21, 2018
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA<sub>2</sub>DS<sub>2</sub>-VA Score Rather Than CHA<sub>2</sub>DS<sub>2</sub>-VASc?Peter Brønnum Nielsen, Flemming Skjøth, Thure Filskov Overvad, et al.
Scientific Reports|June 7, 2016
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort studyPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, et al.
Nature Communications|August 7, 2024
Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohortPeter Brønnum Nielsen, Rasmus Froberg Brøndum, Anne Krogh Nøhr, et al.
Drugs|August 11, 2012
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysisIda Ehlers Albertsen, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, et al.
ESC Heart Failure|February 1, 2018
Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort studyLine Melgaard, Thure Filskov Overvad, Flemming Skjøth, et al.
The American Journal of Medicine|July 8, 2020
Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?Thure Filskov Overvad, Flemming Skjøth, Ida Ehlers Albertsen, et al.
Pageof 5